Related Experiment Video

Updated: Sep 13, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.2K

Respiratory Syncytial Virus in Focus: Emerging Research, Trends, and Clinical Implications

Clare Cardo McKegney1, Margaret Quinn2

  • 1Columbia University, School of Nursing, 560 West 168th Street, New York City, NY 10032, USA.

The Nursing Clinics of North America
|July 27, 2025
PubMed

Insights

Respiratory syncytial virus (RSV) causes severe respiratory infections in young children. New maternal vaccines and infant monoclonal antibodies offer promising prevention strategies to reduce the global burden of this disease.

Area of Science:

  • Pediatrics
  • Virology
  • Infectious Diseases

Background:

  • Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in infants and young children.
  • Severe RSV infections can lead to bronchiolitis, pneumonia, and respiratory failure, particularly in vulnerable populations.

Purpose of the Study:

  • To provide an overview of respiratory syncytial virus (RSV).
  • To highlight current preventive strategies and recent breakthroughs in RSV prevention.
  • To focus on reducing the impact of RSV on high-risk infants and children.

Main Methods:

  • Literature review of current research on RSV.
  • Analysis of recent advancements in RSV prevention, including maternal vaccination and monoclonal antibody therapies.
  • Focus on epidemiological data and clinical outcomes related to RSV.

Main Results:

  • RSV significantly impacts infants under 6 months, preterm infants, and those with comorbidities.
  • Maternal vaccination strategies show potential for protecting infants.
  • Monoclonal antibodies offer passive immunity for high-risk infants.

Conclusions:

  • Recent advancements in RSV prevention, including maternal vaccination and monoclonal antibodies, represent significant breakthroughs.
  • These strategies hold promise for substantially reducing the global burden of RSV in young children.
  • Continued research and implementation are crucial for protecting vulnerable populations from severe RSV disease.

Keywords:
RSV managementRSV preventionRespiratory syncytial virus (RSV)

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.0K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.1K

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
938
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
334
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
368
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
209
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
325
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
589